Focus on Alectinib and Competitor Compounds for Second-Line Therapy in ALK-Rearranged NSCLC

por Tran, Phu N., Klempner, Samuel J.
Publicado 2016

Profile of rociletinib and its potential in the treatment of non-small-cell lung cancer

por Tran, Phu N, Klempner, Samuel J
Publicado 2016

Targeting the Phosphatidylinositol-3-kinase Pathway in Gastric Cancer: Can Omics Improve Outcomes?

por Tran, Phu, Nguyen, Cham, Klempner, Samuel J.
Publicado 2016

Progress and challenges in HER2-positive gastroesophageal adenocarcinoma

por Zhao, Dan, Klempner, Samuel J., Chao, Joseph
Publicado 2019

PD-1 and PD-L1 as emerging therapeutic targets in gastric cancer: current evidence

por Tran, Phu N, Sarkissian, Sarmen, Chao, Joseph, Klempner, Samuel J
Publicado 2017

Advances in immuno-oncology biomarkers for gastroesophageal cancer: Programmed death ligand 1, microsatellite instability, and beyond

por Lin, Emily M, Gong, Jun, Klempner, Samuel J, Chao, Joseph
Publicado 2018

Focal Hepatic Fluorodeoxyglucose Uptake Mimics Liver Metastasis Following External Beam Radiation for Gastroesophageal Cancers: A Case and Review of the Literature

por Wei, Randy, Chaurasia, Avinash, Yu, Suhong, Lall, Chandana, Klempner, Samuel J
Publicado 2016

The impact of gender, race, socioeconomic status, and treatment on outcomes in esophageal cancer: A population-based analysis

por Tran, Phu N., Taylor, Thomas H., Klempner, Samuel J., Zell, Jason A.
Publicado 2017

Cis-oriented solvent-front EGFR G796S mutation in tissue and ctDNA in a patient progressing on osimertinib: a case report and review of the literature

por Klempner, Samuel J, Mehta, Pareen, Schrock, Alexa B, Ali, Siraj M, Ou, Sai-Hong Ignatius
Publicado 2017

Initial Report of Second‐Line FOLFIRI in Combination with Ramucirumab in Advanced Gastroesophageal Adenocarcinomas: A Multi‐Institutional Retrospective Analysis

por Klempner, Samuel J., Maron, Steven B., Chase, Leah, Lomnicki, Samantha, Wainberg, Zev A., Catenacci, Daniel V.T.
Publicado 2018

Real-world Validation of TMB and Microsatellite Instability as Predictive Biomarkers of Immune Checkpoint Inhibitor Effectiveness in Advanced Gastroesophageal Cancer

por Graf, Ryon P., Fisher, Virginia, Creeden, James, Schrock, Alexa B., Ross, Jeffrey S., Nimeiri, Halla, Oxnard, Geoffrey R., Klempner, Samuel J.
Publicado 2022

Early Weight Loss as a Prognostic Factor in Patients with Advanced Gastric Cancer: Analyses from REGARD, RAINBOW, and RAINFALL Phase III Studies

por Mansoor, Wasat, Roeland, Eric J., Chaudhry, Aafia, Liepa, Astra M., Wei, Ran, Knoderer, Holly, Abada, Paolo, Chatterjee, Anindya, Klempner, Samuel J.
Publicado 2021

A Pilot Study of Baseline Spatial Genomic Heterogeneity in Primary Gastric Cancers Using Multi-Region Endoscopic Sampling

por Chao, Joseph, Lee, Jeeyun, Kim, Kyung, Kang, So Young, Lee, Taehyang, Kim, Kyoung-Mee, Kim, Seung Tae, Klempner, Samuel J., Lee, Hyuk
Publicado 2020

Association Between Spatial Heterogeneity Within Nonmetastatic Gastroesophageal Adenocarcinomas and Survival

por Chao, Joseph, Bedell, Victoria, Lee, Jeeyun, Li, Min Sierra, Chu, Peiguo, Yuan, Yate-Ching, Zhao, Dan, Klempner, Samuel J., Lin, Ren-Jang
Publicado 2020

Genomic Alterations of NTRK, POLE, ERBB2, and Microsatellite Instability Status in Chinese Patients with Colorectal Cancer

por Guo, Yun, Guo, Xian‐ling, Wang, Shuang, Chen, Xinyu, Shi, Jiaochun, Wang, Jian, Wang, Kai, Klempner, Samuel J., Wang, Weifeng, Xiao, Min
Publicado 2020

Correlating programmed death ligand 1 (PD-L1) expression, mismatch repair deficiency, and outcomes across tumor types: implications for immunotherapy

por Kim, Seung Tae, Klempner, Samuel J., Park, Se Hoon, Park, Joon Oh, Park, Young Suk, Lim, Ho Yeong, Kang, Won Ki, Kim, Kyoung-Mee, Lee, Jeeyun
Publicado 2017

Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma

por Ang, Celina, Klempner, Samuel J., Ali, Siraj M., Madison, Russell, Ross, Jeffrey S., Severson, Eric A., Fabrizio, David, Goodman, Aaron, Kurzrock, Razelle, Suh, James, Millis, Sherri Z.
Publicado 2019

A Phase 2 Trial Combining Pembrolizumab and Palliative Radiation Therapy in Gastroesophageal Cancer to Augment Abscopal Immune Responses

por Chao, Joseph, He, Ting-Fang, D'Apuzzo, Massimo, Chen, Yi-Jen, Frankel, Paul, Tajon, Michael, Chen, Helen, Solomon, Shawn, Klempner, Samuel J., Fakih, Marwan, Lee, Peter
Publicado 2021

ERBB2 Copy Number as a Quantitative Biomarker for Real-World Outcomes to Anti–Human Epidermal Growth Factor Receptor 2 Therapy in Advanced Gastroesophageal Adenocarcinoma

por Zhang, Liangliang, Hamdani, Omar, Gjoerup, Ole, Cho-Phan, Cheryl, Snider, Jeremy, Castellanos, Emily, Nimeiri, Halla, Frampton, Garrett, Venstrom, Jeffrey M., Oxnard, Geoffrey, Klempner, Samuel J., Schrock, Alexa B.
Publicado 2022

Patient-derived exosomes facilitate therapeutic targeting of oncogenic MET in advanced gastric cancer

por Hyung, Sujin, Ko, Jihoon, Heo, You Jeong, Blum, Steven M., Kim, Seung Tae, Park, Se Hoon, Park, Joon Oh, Kang, Won Ki, Lim, Ho Yeong, Klempner, Samuel J., Lee, Jeeyun
Publicado 2023